Evidence map›Paper›PMID 31353860›Full record

Trial reportAnnals of clinical and translational neurology2019

Early alteration of the locus coeruleus in phenotypic variants of Alzheimer's disease.

Pauline Olivieri, Julien Lagarde, Stéphane Lehericy, Romain Valabrègue, Adeline Michel, Pierre Macé, Fabien Caillé, Philippe Gervais, Michel Bottlaender, Marie Sarazin

Abstract readClinical Trial
In one paragraph

Trial report in Annals of clinical and translational neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Review
  9. Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer's disease.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  20. Oncogenic Pathways in Neurodegenerative Diseases.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pauline OlivieriUnit of Neurology of Memory and Language, Université Paris Descartes, Sorbonne Paris Cité, GHU Paris Psychiatry and Neurosciences, Hôpital Sainte Anne, Paris, France.ORCID 0000-0002-4543-844X
Julien LagardeUnit of Neurology of Memory and Language, Université Paris Descartes, Sorbonne Paris Cité, GHU Paris Psychiatry and Neurosciences, Hôpital Sainte Anne, Paris, France.
Stéphane LehericyInstitut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, F-75013, Paris, France.
Romain ValabrègueInstitut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, F-75013, Paris, France.
Adeline MichelUnit of Neurology of Memory and Language, Université Paris Descartes, Sorbonne Paris Cité, GHU Paris Psychiatry and Neurosciences, Hôpital Sainte Anne, Paris, France.
Pierre MacéUnit of Neurology of Memory and Language, Université Paris Descartes, Sorbonne Paris Cité, GHU Paris Psychiatry and Neurosciences, Hôpital Sainte Anne, Paris, France.
Fabien CailléUMR 1023, IMIV, Service Hospitalier Frédéric Joliot, CEA, Inserm, Université Paris Sud, CNRS, Université Paris-Saclay, Orsay, France.
Philippe GervaisUMR 1023, IMIV, Service Hospitalier Frédéric Joliot, CEA, Inserm, Université Paris Sud, CNRS, Université Paris-Saclay, Orsay, France.
Michel BottlaenderUMR 1023, IMIV, Service Hospitalier Frédéric Joliot, CEA, Inserm, Université Paris Sud, CNRS, Université Paris-Saclay, Orsay, France.
Marie SarazinUnit of Neurology of Memory and Language, Université Paris Descartes, Sorbonne Paris Cité, GHU Paris Psychiatry and Neurosciences, Hôpital Sainte Anne, Paris, France.

Funding

Association France AlzheimerCEA 100033Fondation pour la recherche sur AlzheimerFrench Health Ministry 2013-0919Institut de Recherches International Servier
6 · The paper itself

Abstract

Neuropathological studies showed early locus coeruleus (LC) neuronal loss associated with tauopathy in Alzheimer's Disease (AD). We used the LC signal intensity (LC-I) on 3T MRI to assess the LC integrity in AD (n = 37) and controls (n = 17). The LC-I was decreased in AD regardless of typical (amnesic) and atypical presentation (logopenic aphasia/visuo-spatial deficit), from the prodromal stage, and independently of the amyloid load measured by PiB-PET. The LC-I was correlated with memory performance of typical AD. This supports the pathophysiological model in which the LC plays a critical role in AD and may thus be a potential therapeutic target.

Indexed as

AgedAlzheimer DiseaseAmyloidFemaleHumansLocus CoeruleusMaleMiddle AgedAmyloid

Identifiers

PMID31353860
PMCPMC6649639

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.